EARS - Auris Medical starts preparations for COVID-19 trial with Bentrio in India
Auris Medical Holding (EARS) announces that its affiliate Altamira Medica has started preparations to conduct a study with its Bentrio nasal spray for protection against airborne viruses and allergens in India.The study will seek to evaluate the efficacy of Bentrio in the prevention and treatment of acute Covid-19 and shall start recruitment in Q3 2021 subject to regulatory and ethics committee approval.Shares up marginally during premarket trading.
For further details see:
Auris Medical starts preparations for COVID-19 trial with Bentrio in India